These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8013781)

  • 1. [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus].
    Robaszkiewicz M; Hardy E; Volant A
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D35-9. PubMed ID: 8013781
    [No Abstract]   [Full Text] [Related]  

  • 2. Barrett's esophagus: the biology of neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Levine DS; Reid BJ
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D71-6. PubMed ID: 8013790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
    Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
    Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy.
    Lin X; Finkelstein SD; Zhu B; Ujevich BJ; Silverman JF
    Cancer; 2009 Feb; 117(1):57-66. PubMed ID: 19347831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
    Fang M; Lew E; Klein M; Sebo T; Su Y; Goyal R
    Am J Gastroenterol; 2004 Oct; 99(10):1887-94. PubMed ID: 15447746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma.
    Fein M
    Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the TP53 tumor suppressor gene in malignant transformation of Barrett esophagus].
    Ferec C; Audrezet MP; Mercier B; Robaszkiewicz M
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D46-51. PubMed ID: 8013783
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus: a model of human neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta 1 integrin expression in adenocarcinoma of Barrett's esophagus.
    Bottger TC; Youssef V; Dutkowski P; Seifert J; Maschek H; Brenner W; Junginger T
    Hepatogastroenterology; 1999; 46(26):938-43. PubMed ID: 10370643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Barrett's adenocarcinoma.
    Melzer E; Shtoyerman R; Appelman Z; Kashtan H
    Am J Gastroenterol; 2006 Mar; 101(3):677. PubMed ID: 16542304
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel genetic marker for dilated end stage oesophagus and oesophageal adenocarcinoma risk?
    Lenglinger J; Riegler M
    Gut; 2010 Feb; 59(2):275; author reply 275. PubMed ID: 20176646
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's: do we still need goblet cells for diagnosis?
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions.
    Zhang X; Huang Q; Goyal RK; Odze RD
    Am J Surg Pathol; 2008 Sep; 32(9):1327-35. PubMed ID: 18670357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.